Insider Purchases: Inside the Buy
Tag: Short Squeeze
AbCellera (ABCL) Stock Analysis: 7 Triggers for a Biotech Short Squeeze or Long-Term Multibagger?
Down 95%, heavily shorted, yet sitting on $700M in liquidity and insider conviction — AbCellera (ABCL) may be biotech’s ultimate asymmetric bet.
Ryan Cohen Buys More GameStop; Time to Play — or Make This Story Short?
Ryan Cohen doubles down on GameStop. Shorts stay crowded. Analysts stay bearish. But profits, cash, and conviction are back. Is GME still a meme — or a mispriced turnaround? 🎯🎮
Insiders Purchase Shares of Goosehead Insurance — Should You Buy, Duck, or Just Take a Gander?
Insiders are loading up on Goosehead Insurance shares — and institutions can’t get enough. With strong growth but real risks, is this goose ready to fly… or cooked? Here’s the fun, smart breakdown. 🪿📈🔥
Insiders Pile Into Opendoor (OPEN) as New CEO Kasra Nejatian Bets on an ‘AI-First, Software-First’ Future — Should You Join the Cult Stock Rally?
Insiders are buying, retail traders are chanting, and Opendoor has a new AI-first CEO. From near-delisting to cult stock darling — is OPEN worth the hype?
GameStop (GME) Reloaded: Profits, Bitcoin, and Insider Power-Ups
Gamestop (GME) is back in the spotlight, and CEO Ryan Cohen is betting big on it. But is this a high-reward investment or a risky gamble? With new business pivots, crypto investments, and insider confidence, Gamestop might just have more game to play.